Komori
Silicon Studio Corp. (3907) · RiskRestated

Impact of COVID-19 on Order Acquisition Activities and Business Performance

First written in FY2020-Q2. 10 of 12 entries say "Restated". Latest entry: FY2023.

12entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2020-Q2 – FY2020-Q3RestatedFY2020 – FY20232020: 220202021: 320212022: 320222023: 320232024: 12024
Same theme, other companies
Stagnation of Sales Activities and Business Negotiations Due to COVID-19A theme 55 companies write about · 55 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 23 of 48 companies on the "Worse" side.

18 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 55 companies compared. The sentences above are computed from all 55.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「The spread of infectious diseases such as COVID-19 may also affect the Group's business activities. With regard to order-taking risks, if the postponement or cancellation of trade shows is prolonged, opportunities to present the Group's new products and technologies may be lost, and the acquisition of new projects may not progress as expected.」

    The Company continues to identify the risks of losing trade shows and sales opportunities and delays in acquiring new projects and selling products due to the spread of infectious diseases.
  2. FY2023-Q3RestatedAnnual report

    「There have been no material changes in the assumptions concerning the impact of the spread of COVID-19 described in the notes to the securities report for the previous consolidated fiscal year.」

    The Company has reconfirmed that there have been no material changes to its accounting assumptions concerning the impact of COVID-19.
  3. FY2023-Q2RestatedAnnual report

    「There have been no material changes in the assumptions concerning the impact of the spread of COVID-19 described in the notes to the securities report for the previous consolidated fiscal year.」

    The Company has reconfirmed that there have been no material changes to its accounting assumptions concerning the impact of COVID-19.
  4. FY2023-Q1RestatedAnnual report

    「There have been no material changes in the assumptions concerning the impact of the spread of COVID-19 described in the notes to the securities report for the previous consolidated fiscal year.」

    The Company has reconfirmed that there have been no material changes to its accounting assumptions concerning the impact of COVID-19.
  5. FY2022-Q3RestatedAnnual report

    「There have been no material changes in the assumptions concerning the impact of the spread of COVID-19 described in the notes to the securities report for the previous consolidated fiscal year.」

    The Company has reconfirmed that there have been no material changes to its accounting assumptions concerning the impact of COVID-19.
  6. FY2022-Q1RestatedAnnual report

    「There have been no material changes in the assumptions concerning the impact of the spread of COVID-19 described in the notes to the securities report for the previous consolidated fiscal year.」

    The Company has reconfirmed that there have been no material changes to its accounting assumptions concerning the impact of COVID-19.
  7. FY2021RestatedAnnual report

    「If COVID-19 continues for an extended period, the Group's business activities may also be affected. With regard to order-taking risks, if the postponement or cancellation of trade shows is prolonged, opportunities to present the Group's new products and technologies may be lost, and the acquisition of new projects may not progress as expected.」

    The Company continues to identify the risks of losing trade shows and sales opportunities and delays in acquiring new projects and selling products if the pandemic is prolonged.
  8. FY2021-Q2RestatedAnnual report

    「As stated in item (7) of “Part I. Corporate Information, Section 2. Business Overview, 2. Business and Other Risks” in the annual securities report for the previous fiscal year, the Company has disclosed the risks related to COVID-19 and will continue to closely monitor its impact on the business.」

    The Company says there have been no material changes to the risks related to COVID-19 and will continue to monitor the impact on its business.
  9. FY2021-Q1RestatedAnnual report

    「As stated in item (7) of “Part I. Corporate Information, Section 2. Business Overview, 2. Business and Other Risks” in the annual securities report for the previous fiscal year, the Company has disclosed the risks related to COVID-19 and will continue to closely monitor its impact on the business.」

    The Company says there have been no material changes to its existing disclosure of COVID-19-related risks and will continue to monitor the impact on its business.
  10. FY2020RestatedAnnual report

    「If COVID-19 continues for an extended period, the Group's business activities may also be affected. With regard to order-taking risks, if the postponement or cancellation of trade shows is prolonged, opportunities to present the Group's new products and technologies may be lost, and the acquisition of new projects may not progress as expected. In addition, if customers' earnings deteriorate and they significantly restrain spending or postpone decisions on new investments, sales of the Group's products and services may not progress as expected.」

    The Company identifies as risks not only the loss of trade shows and sales opportunities due to the pandemic, but also delays in product and service sales caused by customers restraining investment.
  11. FY2020-Q3WorsenedAnnual report

    「During the current third quarter of the consolidated fiscal year, further spread of COVID-19 caused economic and business activity to stagnate, and sentiment deteriorated significantly across a broad range of sectors. Although economic activity has recently begun to resume gradually and a gradual recovery in demand is expected, the Company has reflected accounting estimates in its accounting based on information available at this time, assuming that the impact will inevitably continue through the end of the current consolidated fiscal year.」

    Regarding the impact of COVID-19, the Company describes the stagnation of economic and business activity and the significant deterioration in business sentiment caused by further spread of the virus, and reflected the assumption that the impact would continue through the fiscal year-end in its accounting estimates.
  12. FY2020-Q2MaterialisedAnnual report

    「The spread of COVID-19 may affect the financial position and operating results of the Group, and the Company will continue to closely monitor developments. The spread of COVID-19 has also disrupted order-taking activities, including through the cancellation of trade show participation and the suspension of in-person sales activities.」

    The Company states that COVID-19 may affect its financial position and operating results and that order-taking activities have actually been disrupted by cancelled trade shows and the suspension of in-person sales activities.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Silicon Studio Corp. yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 on Order Acquisition Activities and Business Performance | Silicon Studio Corp. (3907) | Komori